Now available in select US geographies.

Avation Medical adds Vice President of Product Marketing and Customer Care

          New VP will market the Vivally® System for 46 million people in the U.S. with overactive bladder

Columbus, OH (June 12, 2024) – Avation Medical, an innovative neuromodulation and digital
health company on a mission to make non-invasive, physiologic, closed-loop neuromodulation
accessible to patients across a variety of clinical conditions, has named Jennifer Estep Vice
President of Product Marketing and Customer Care for its newly launched Vivally System.
Vivally is the first FDA-cleared non-invasive, physiological closed-loop neuromodulation system
to treat overactive bladder (OAB). Estep will play a pivotal role in expanding awareness and
differentiating Vivally from other treatment options that require surgery, drugs, or needles.

“As a mechanical engineer, with deep experience in product design, development, marketing,
and commercialization, Jennifer brings broad and deep perspective to all aspects of our
organization,” said Jill Schiaparelli, founder and CEO of Avation Medical. 

Over the past decade, Estep has held leadership positions in the medtech and pharmaceutical
industries, building and leading high-impact teams to bring patient-centric products to market.
Most recently, she served as Senior Director of Global Marketing and Commercial Strategy at
Enable Injections, Inc. 

Schiaparelli adds that Estep will accelerate the marketing of Vivally, which is already gaining
traction with OAB specialists and patients. “OAB is a chronic condition, yet nearly 90 percent of
patients drop out of the care pathway after just two years because their choices are invasive and            inconvenient; we see a significant opportunity to make a positive difference in people’s lives with a               non-invasive neuromodulation therapy.”

Using proprietary algorithms and electromyographical (EMG) sensors, Vivally continuously
reads the patients EMG signal and automatically adjusts the level of stimulation energy being
delivered to a patient’s tibial nerve to ensure optimal, customized therapy in a real-time,
closed-loop system. Worn on the ankle, Vivally is used by patients at home for therapy sessions
lasting only 30 minutes as little as once per week. Because Vivally requires no surgery, drugs, or
needles, it represents a groundbreaking advancement in the treatment of OAB. 

In two multi-center randomized clinical trials, the Vivally System was shown to significantly
reduce daily void, incontinence, and urgency episodes and improve patient quality of life while
facilitating an 89-percent therapy compliance rate. Symptom reduction was demonstrated out
to one year, even with decreasing therapy frequency over time. 

The Vivally System 

is a convenient, next-generation, at-home wearable neuromodulation
therapy that is discreet, comfortable, and easy to use. Urology teams collaborate with their
patients through online diaries and individualized data to validate, treat, and monitor
symptoms for optimal patient success. Clinicians can increase the number of patients they are
able to effectively treat while reducing the cost of care, thus positively impacting patients, their
practices, and the healthcare system overall. 

About Avation Medical and the Vivally System 

Avation Medical is an innovative neuromodulation and digital health company with a mission to make non-invasive, physiologic closed-loop neuromodulation accessible to patients across a variety of clinical conditions. The company’s Vivally System is the only FDA-cleared, physiologic closed-loop, at-home wearable neuromodulation device system to treat symptoms of OAB. Combined with a companion mobile application, Vivally offers a comprehensive therapy and support system for patients suffering from urge urinary incontinence and urinary urgency caused by overactive bladder syndrome (OAB). Vivally is prescribed by a clinician following a brief clinical calibration which establishes an EMG target and range of neuromodulation energy needed for consistent nerve activation. Vivally delivers clinically effective therapy in just 30 minute sessions, as little as once per week. Vivally is available by prescription in select geographies in the United States. Learn more at Avation.com.  

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Skip to content